20.2.2025 08:00:00 CET | Thor Medical ASA | Non-regulatory press releases
Thor Medical ASA will release its second half and full year results 2024 on Wednesday 26 February 2025 at 07:00 am (CEST). A presentation of the results followed by a Q&A session will be held on the same day at 08:00 am at Carnegie’s offices at Aker Brygge, Fjordalleen 16, and through a live webcast. The presentation and the Q&A session can be followed through a live webcast from our website www.thormedical.com or using the following link: Thor Medical Webcast 2H 2024.
Contacts
Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com
About Thor Medical ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
To learn more, visit www.thormedical.no.
Attachments
Download announcement as PDF.pdf
